Protein Therapeutics Market to Garner $566.66 Bn, Globally, by 2030 at 7.1% CAGR: Allied Market Research

Surge in the prevalence of chronic diseases and increase in proteomics research have boosted the growth of the global protein therapeutics market.

PORTLAND, Ore., March 29, 2022 /PRNewswire/ -- Allied Market Research recently published a report, titled, "Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030". As per the report, the global protein therapeutics industry accounted for $283.64 billion in 2020, and is expected to reach $566.66 billion by 2030, growing at a CAGR of 7.1% from 2021 to 2030.

Download Sample Report- https://www.alliedmarketresearch.com/request-sample/60

Major determinants of the market growth

Surge in the prevalence of chronic diseases and increase in proteomics research have boosted the growth of the global protein therapeutics market. However, high production costs required for developing and manufacturing protein-based therapeutics hinder the market growth. On the contrary, surge in healthcare expenditure and increase in geriatric populations would open new opportunities for the market players in the future.

Covid-19 scenario:

• The Covid-19 pandemic had a positive impact on the growth of protein therapeutics due to surge in chronic diseases and increase in demand for therapeutic drugs.
• The number of clinics and hospitals across the globe increased during the pandemic, which supplemented the demand for protein therapeutics.
• However, the prolonged lockdown and disruptions of manufacturing and transportation of healthcare essentials hinder the market.

Get detailed COVID-19 impact analysis on the Protein Therapeutics Market- https://www.alliedmarketresearch.com/request-for-customization/60?reqfor=covid

The metabolic disorders segment dominated the market growth

By application, the metabolic disorders segment held the largest share in 2020, accounting for around one-fifth of the market, due to surge in the number of metabolic disorders, especially diabetes. However, the cancer segment is expected to register the highest CAGR of 9.1% during the forecast period, owing to surge in cancer cases and increase in demand for personalization of treatments.

The fusion protein segment to manifest the highest CAGR through 2030

By product, the fusion protein segment is expected to register the highest CAGR of 9.5% during the forecast period, owing to advantages of the fusion protein over other conventional products and enhanced product homogeneity. However, the monoclonal antibodies segment is expected to hold the largest share in 2020, contributing to nearly half of the market, due to wide availability and application to treat various chronic diseases.

North America held the largest share

By region, the market across North America dominated the market in 2020, holding nearly half of the market, due to increase in chronic diseases, rapid adoption of advanced technologies, and presence of key players in the region. However, the market across Asia-Pacific is expected to register the highest CAGR of 8.7% during the forecast period, owing to rapidly growing geriatric population, surge in public-private investment, and increase in number of initiatives for healthcare awareness.

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/60

Major market players

• Abbott Laboratories
• Baxter International Inc.
• Amgen Inc.
• F. Hoffmann-La Roche Ltd.
• Eli Lilly and Company
• Merck & Co., Inc.
• Johnson & Johnson (Janssen Pharmaceuticals)
• Pfizer Inc.
• Novo Nordisk A/S
• Sanofi

Official Press Release- https://www.alliedmarketresearch.com/press-release/protein-therapeutics-market.html

Similar Research Reports for Information, Communication and Technology:

Cough Syrup Market - Global Opportunity Analysis and Industry Forecast, 2021–2030

Gloves market- Global Opportunity Analysis and Industry Forecast, 2021–2030

Influenza Treatment Market - Global Opportunity Analysis and Industry Forecast, 2021–2030

Bone Growth Stimulators Market - Global Opportunity Analysis and Industry Forecast, 2021–2030

Palliative Care Market- Global Opportunity Analysis and Industry Forecast, 2021–2030 

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model):

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]  
Web: https://www.alliedmarketresearch.com  

SOURCE Allied Market Research